California State Teachers Retirement System trimmed its holdings in shares of Hologic, Inc. (NASDAQ:HOLX) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 457,451 shares of the medical equipment provider’s stock after selling 4,315 shares during the period. California State Teachers Retirement System owned about 0.16% of Hologic worth $18,801,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Robeco Institutional Asset Management B.V. grew its stake in Hologic by 92.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 22,272 shares of the medical equipment provider’s stock valued at $913,000 after buying an additional 10,722 shares during the last quarter. Bessemer Group Inc. grew its stake in Hologic by 122.4% in the 3rd quarter. Bessemer Group Inc. now owns 3,534 shares of the medical equipment provider’s stock valued at $145,000 after buying an additional 1,945 shares during the last quarter. LSV Asset Management bought a new stake in Hologic in the 3rd quarter valued at $1,319,000. SG Americas Securities LLC boosted its holdings in Hologic by 167.8% in the 3rd quarter. SG Americas Securities LLC now owns 93,708 shares of the medical equipment provider’s stock valued at $3,840,000 after purchasing an additional 58,717 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in Hologic by 1.8% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 871,667 shares of the medical equipment provider’s stock valued at $35,721,000 after purchasing an additional 15,375 shares during the period. Institutional investors own 88.77% of the company’s stock.
In other news, insider Peter J. Valenti III sold 4,242 shares of the firm’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $47.38, for a total transaction of $200,985.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Benjamin Jordan Cohn sold 6,830 shares of the firm’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $46.70, for a total transaction of $318,961.00. Following the transaction, the insider now directly owns 22,002 shares of the company’s stock, valued at $1,027,493.40. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.
A number of analysts have weighed in on the stock. BidaskClub raised shares of Hologic from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 21st. Piper Jaffray Companies increased their price target on shares of Hologic to $49.00 and gave the company an “overweight” rating in a report on Thursday, January 31st. BTIG Research reissued a “buy” rating and issued a $50.00 price target on shares of Hologic in a report on Thursday, January 31st. Zacks Investment Research downgraded shares of Hologic from a “buy” rating to a “hold” rating in a report on Thursday, February 21st. Finally, Morgan Stanley downgraded shares of Hologic from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $44.00 to $39.00 in a report on Wednesday, January 2nd. One analyst has rated the stock with a sell rating, nine have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $44.52.
NASDAQ:HOLX opened at $47.63 on Friday. The stock has a market cap of $13.74 billion, a PE ratio of 21.36, a price-to-earnings-growth ratio of 2.21 and a beta of 0.75. Hologic, Inc. has a 52 week low of $35.10 and a 52 week high of $48.11. The company has a quick ratio of 0.91, a current ratio of 1.30 and a debt-to-equity ratio of 1.18.
Hologic (NASDAQ:HOLX) last released its quarterly earnings data on Wednesday, January 30th. The medical equipment provider reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.01. The company had revenue of $830.70 million during the quarter, compared to the consensus estimate of $823.22 million. Hologic had a negative net margin of 12.88% and a positive return on equity of 25.59%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $0.55 EPS. On average, equities research analysts expect that Hologic, Inc. will post 2.41 EPS for the current year.
TRADEMARK VIOLATION WARNING: This report was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.americanbankingnews.com/2019/03/17/hologic-inc-holx-stake-lowered-by-california-state-teachers-retirement-system.html.
Hologic Company Profile
Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Read More: How a Put Option Works
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.